Showing 181-190 of 217 results for "".
The Hidradenitis Suppurativa Therapeutic Pipeline
https://practicaldermatology.com/topics/rare-disease/the-hidradenitis-suppurativa-therapeutic-pipeline/54824/Though treatment options are currently limited, the pipeline for HS therapeutics is active with numerous medications in development.First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Lose Your Inhibitions: Expanding Use of JAK Inhibitors
https://practicaldermatology.com/topics/atopic-dermatitis/lose-your-inhibitions-expanding-use-of-jak-inhibitors/23910/Despite data on safety concerns, dermatologists and patients see benefits.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-33/23690/Currents: Spotlight on Biologics
https://practicaldermatology.com/topics/psoriasis/currents-spotlight-on-biologics/23548/Currents
https://practicaldermatology.com/topics/practice-management/currents-7/23346/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20393/Currents
https://practicaldermatology.com/topics/practice-management/currents/21012/Social Bullying: What's Our Role in It?
https://practicaldermatology.com/topics/practice-management/social-bullying-whats-our-role-in-it/21187/Evaluating the Interleukin Antibodies and Their Future in Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0809_13-php/22791/New investigational therapies blocking IL-12/23 may offer new possibilities in the treatment of psoriatic disease.